Catalyst Biosciences (NASDAQ:CBIO) reported quarterly earnings of $1.64 per share. This is a 356.25 percent increase over losses of $(0.64) per share from the same period last year.
Here’s How Analysts Reacted To Workday’s Q4 Results
Analysts mostly raised their price targets on Workday Inc (NASDAQ:WDAY) post Q4 results. Wells Fargo analyst Michael Turrin raised the PT to…